Скачать или смотреть How MSQ Helped BiolineRX and GloriaBio: MSQ Client Stories

Closing a life-changing biotech deal while in the NICU with my newborn daughter—this was more than business. It was personal.

In 2022, @Philip A. Serlin, CEO of @BioLineRX, sought our expertise to secure the right partner for their pancreatic cancer drug—an area with high clinical trial failure rates. Having lost my uncle to this disease, I was deeply committed.

🔹 Facilitated a trial collaboration between BioLineRX & Genfleet
🔹 Secured @GloriaBio as the ideal partner to bring the drug to market
🔹 Accelerated the deal—finalized all agreements in just 3 months, fast-tracking patient access

During final negotiations, I joined remotely—from the NICU, holding my newborn daughter. Balancing new motherhood and high-stakes dealmaking only strengthened my resolve.

At MSQ, we don’t just close deals—we accelerate innovation and help life-saving treatments reach patients faster.

Grateful to partner with BioLineRX, GloriaBio, and biotech leaders to turn bold visions into reality. If you’re working on groundbreaking therapies, let’s connect.

Visit our website for more info

#Biotech #Partnerships #CancerResearch #LifeSciences #MSQ